Learn & Apply Paradigm in Drug Development: How disease-drug-trial models can aid decisions
Joga Gobburu, PhD, Division of Parmacometrics, OCP/FDA
Dr. Gobburu’s talk will summarize the state of the art in applying drug-disease-trial models to decision-making processes in drug development.
A message from Dr. Gobburu:
The following articles may serve as a good background for the upcoming webinar on 'Learn & Apply Paradigm to Drug Development'.
Gobburu JV. Pharmacometrics 2020. J Clin Pharmacol. 2010 Sep;50(9 Suppl):151S-157S.Gobburu JV, Lesko LJ. Quantitative disease, drug, and trial models. Annu Rev Pharmacol Toxicol. 2009;49:291-301.Gobburu J. Disease models. Clin Adv Hematol Oncol. 2008 Apr;6(4):241-2.